下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemETanespimycinCat. No.: HY-10211CAS No.: 75747-14-7Synonyms: 17-AAG; NSC 330507; CP 127374分式: CHNO分量: 585.69作靶点: HSP; Autophagy; Mitophagy作通路: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease;Autophagy储存式: 4C, protect from light*
2、In solvent : -80C, 6 months; -20C, 1 month (protect fromlight)溶解性数据体外实验 DMSO : 55 mg/mL (93.91 mM)H2O : 0.1 mg/mL (insoluble)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.7074 mL 8.5369 mL 17.0739 mL5 mM 0.3415 mL 1.7074 mL 3.4148 mL10 mM 0.1707 mL 0.85
3、37 mL 1.7074 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Tanespimycin (17-AAG)有效的 HSP90 抑制剂,IC50 为 5 nM,对肿瘤细胞 HSP90 的亲和性正常细胞100 倍。IC50 & Target HSP90 Autophagy Mitophagy1/3 Master of Small Molecules 您边的抑制剂师www.MedChemE5 nM (IC50)体外研究 Tanespimycin causes the degradation of HE
4、R2, Akt, and both mutant and wild-type AR and theretinoblastoma-dependent G1 growth arrest of prostate cancer cells. Tanespimycin inhibits prostate cancercell lines with IC50s ranged from 25-45 nM (LNCaP, 25 nM; LAPC-4, 40 nM; DU-145, 45 nM; and PC-3, 25nM) 1. Tanespimycin (0.1-1 M) induces a nearly
5、 complete loss of ErbB2 on ErbB2-overexpressing breastcancer cells 2. Tanespimycin inhibits cell growth and induces G2/M cell cycle arrest and apoptosis in CCAcells together with the down-regulation of Bcl-2, Survivin and Cyclin B1, and the up-regulation of cleavedPARP 3.体内研究 Tanespimycin (25-200 mg
6、/kg, i.p.) causes a dose-dependent decline in AR, HER2, and Akt expression inprostate cancer xenografts. Tanespimycin treatment at doses sufficient to induce AR, HER2, and Aktdegradation results in the dose-dependent inhibition of androgen-dependent and -independent prostatecancer xenograft growth w
7、ithout toxicity 1. Tanespimycin (60 mg/kg) with Rapamycin (30 mg/kg) inhibitsA549 and MDA-MB-231 tumor growth and effects tumor cures in MDA-MB-231 tumor-bearing animals by tailvein injection 4.PROTOCOLCell Assay 1 For the Alamar Blue proliferation assay, 2-4103 cells are plated in 96-well plates. L
8、ater (48 h), cells aretreated with Tanespimycin for 96 h or 0.01% DMSO as control. On day 4, Alamar Blue viability assay isperformed as described elsewhere. IC50 and IC90s are calculated as the doses of Tanespimycin required toinhibit cell growth by 50 and 90%, respectively. Cell cycle distribution
9、is assayed as described previously witha Becton Dickinson fluorescence-activated cell sorter and analyzed by the Cell Cycle Multicycle system.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Tanespimycin is dissolved in an EPL vehicle. To aid in t
10、he identification of an optimal dose and schedule,Administration 1 nontumor bearing mice are treated by i.p. injection with 25-200 mg/kg of Tanespimycin 5 days/week for 3weeks or by the EPL vehicle alone. Serum samples are taken from each group, and equal volumes arepooled on days 5, 10, and 15 of t
11、reatment for serum chemistry and liver function analysis. At sacrifice,plasma samples are collected for complete blood count. A gross necropsy is performed on all of the mice,and a complete necropsy, including histopathology, is performed on 1 animal/group.MCE has not independently confirmed the acc
12、uracy of these methods. They are for reference only.户使本产品发表的科研献 Theranostics. 2018 Feb 15;8(7):2044-2060. Cell Death Dis. 2018 Feb 7;9(2):165. J Exp Clin Cancer Res. 2018 Mar 27;37(1):70. Mol Cancer Ther. 2016 Sep;15(9):2107-18. Front Mol Neurosci. 2018 Nov 6;11:401.See more customer validations on
13、HYPERLINK / www.MedChemE2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEREFERENCES1. Solit DB, et al. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits thegrowth of prostate cancer xenografts.Clin Cancer Res, 2002, 8(5), 986-993.2. Raja,
14、Srikumar M., et al. 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation andcytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biology & Therapy (2008), 7(10), 1633. Zhang J, et al. The heat shock protein 90 inhibitor 17-AAG suppresses growth and i
15、nduces apoptosis in human cholangiocarcinomacells.Clin Exp Med. 2012 Sep 7.4. Newman B, et al. HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells.Cancer Res. 2012 Sep 1;72(17):4551-61. Epub2012 Jun 29.5. Kamal A, et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 20
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年度宠物养护服务中介担保服务条款3篇
- 2024-2030年中国垃圾发电行业发展困境与十三五投资建议报告
- 2024-2030年中国卫浴五金行业市场竞争战略及发展潜力研究报告
- 2024年物业管理合作协议模板6篇
- 2024年机器操作安全合同3篇
- 满洲里俄语职业学院《进出口业务实操二》2023-2024学年第一学期期末试卷
- 漯河医学高等专科学校《酒店管理信息化软件实验》2023-2024学年第一学期期末试卷
- 2024套房智能家居系统设计与安装服务合同
- 2025微博微信广告发布合同书
- 单位人力资源管理制度品读选集
- 朝花夕拾-无常解析
- 餐饮服务电子教案 学习任务4 鸡尾酒调制
- 慢性阻塞性肺疾病(COPD)护理查房
- 2024年商铺租赁终止合同范本(四篇)
- 康养运营方案
- 安保行业培训合同
- TSG 23-2021 气瓶安全技术规程 含2024年第1号修改单
- 2024-2030年聚甲基丙烯酸甲酯(PMMA)行业市场现状供需分析及投资评估规划分析研究报告
- 弹性力学仿真软件:Altair HyperWorks:HyperStudy设计研究与优化教程
- 教科版小学科学六年级上册期末考试试卷(含答案)
- 北京课改版小学英语五年级上册-知识清单
评论
0/150
提交评论